HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saskia J A M Santegoets Selected Research

Neoplasm Antigens (Tumor Antigens)

6/2013Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.
9/2010Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Saskia J A M Santegoets Research Topics

Disease

18Neoplasms (Cancer)
01/2019 - 12/2006
6Melanoma (Melanoma, Malignant)
04/2016 - 07/2008
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2018 - 03/2006
3Leukemia
10/2018 - 12/2008
2Squamous Cell Carcinoma of Head and Neck
01/2018 - 06/2013
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 06/2013
2Ovarian Neoplasms (Ovarian Cancer)
10/2015 - 02/2013
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Ovarian Epithelial Carcinoma
10/2015
1Fatigue
10/2015
1Colonic Neoplasms (Colon Cancer)
01/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2015
1Hashimoto Disease (Thyroiditis, Hashimoto)
01/2015
1Breast Neoplasms (Breast Cancer)
06/2013
1Wilms Tumor (Wilm's Tumor)
04/2013
1Pathologic Complete Response
04/2013
1Neoplasm Metastasis (Metastasis)
04/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013
1Prostatic Neoplasms (Prostate Cancer)
05/2012
1Infections
04/2010
1Colorectal Neoplasms (Colorectal Cancer)
08/2007

Drug/Important Bio-Agent (IBA)

6VaccinesIBA
01/2019 - 12/2008
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2019 - 03/2006
5AntigensIBA
10/2018 - 12/2006
5CytokinesIBA
01/2018 - 03/2006
3Peptides (Polypeptides)IBA
10/2015 - 12/2006
3EpitopesIBA
01/2015 - 08/2007
3IpilimumabIBA
01/2015 - 05/2012
3DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
04/2013 - 04/2008
2Cancer VaccinesIBA
01/2015 - 08/2007
2Neoplasm Antigens (Tumor Antigens)IBA
06/2013 - 09/2010
2Interleukin-10 (Interleukin 10)IBA
04/2013 - 01/2013
2SuspensionsIBA
02/2013 - 09/2010
1OligodeoxyribonucleotidesIBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1ChemokinesIBA
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1Viral AntigensIBA
01/2018
1PlatinumIBA
10/2015
1p53 synthetic long peptide vaccineIBA
10/2015
1peginterferon alfa-2b (Pegintron)FDA Link
10/2015
1GemcitabineFDA Link
10/2015
1AntibodiesIBA
01/2015
1GVAX vaccineIBA
01/2015
1ThyroglobulinFDA Link
01/2015
1SurvivinIBA
06/2013
1InterleukinsIBA
04/2013
1Interleukin-2 (IL2)IBA
02/2013
1Biomarkers (Surrogate Marker)IBA
02/2013
1CTLA-4 AntigenIBA
05/2012
1LigandsIBA
02/2012
1Antiviral Agents (Antivirals)IBA
04/2010
1ProMune (CpG 7909)IBA
07/2008
1Complementary DNA (cDNA)IBA
08/2007
1Immunoglobulin G (IgG)IBA
08/2007
1Carcinoembryonic AntigenIBA
12/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2006
1Interleukin-4 (Interleukin 4)IBA
03/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2006

Therapy/Procedure

11Immunotherapy
09/2016 - 04/2008
2Therapeutics
01/2018 - 02/2013
1Injections
04/2016
1Drug Therapy (Chemotherapy)
10/2015
1Aftercare (After-Treatment)
01/2015
1Castration
05/2012